Morningstar Investment Management LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB)

Morningstar Investment Management LLC purchased a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 1,875 shares of the biotechnology company’s stock, valued at approximately $534,000. Several other institutional investors also recently added to or reduced their stakes in […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set The Goldman Sachs Group, Inc. (NYSE:GS) Target Price at $393.76
Next post Financial Survey: Red Robin Gourmet Burgers (NASDAQ:RRGB) versus Reborn Coffee (NASDAQ:REBN)